Block analysts lower price targets after a Q4 that missed revenue and earnings per share estimates. Analysts see short-term weakness with 2025 heavily weighted to the second half of the year for the company's potential growth.

GRAND CAYMAN, Cayman Islands, Feb. 21, 2025 ( GLOBE NEWSWIRE ) -- SRIVARU Holding Limited ( OTC: SVUHF ) ( "SRIVARU" or the "Company" ) , has been made aware of a legal claim against the Company by Sabby Volatility Warrant Master Fund Ltd. ( "Sabby" ) in the Supreme Court of the State of New ...

WARREN, N.J., Feb. 21, 2025 ( GLOBE NEWSWIRE ) -- Tevogen Bio ( "Tevogen Bio Holdings Inc." or "Company" ) ( Nasdaq: TVGN ) , a clinical-stage specialty immunotherapy biotech company, aims to set new efficiency standards in the industry, to prove that innovation and cost-effectiveness can ...

The hearings in both chambers of Congress will contemplate CBDCs, stablecoins, and market structure legislation.

FDA approves Mirum's Ctexli, the first treatment for cerebrotendinous xanthomatosis, a rare genetic disorder affecting fat metabolism. In a trial, Ctexli significantly reduced cholesterol metabolites linked to CTX, but it carries a liver toxicity warning requiring monitoring

The DOJ and SEC is reportedly investigating CrowdStrike's $32 million deal with Carahsoft. The deal between CrowdStrike and Carahsoft, a technology distributor, aimed to provide cybersecurity tools to the IRS.

Deep-pocketed investors have adopted a bullish approach towards MicroStrategy MSTR, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.

VanEck proposes a strategic bitcoin reserve, accumulating 1 million BTC by 2029, to help offset $21 trillion in U.S. national debt by 2049. Prediction markets show rising odds of a federal Bitcoin reserve.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. JP Morgan analyst Rajat Gupta downgraded the rating for TrueCar, Inc.

Insulet's Q4 revenue hit $597.5 million, up 17.2%, beating the $582.81 million consensus. Omnipod revenue climbed 16.9% to $585.7 million, with international sales up 33.5%. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market insights.